Literature DB >> 34357679

Broaching goals-of-care conversations in advancing pediatric cancer.

Erica C Kaye1, Cameka Woods1, Srilakshmi Velrajan2, Monica E Lemmon3, Justin N Baker1, Jennifer W Mack4,5.   

Abstract

Broaching conversations about goals of care can be difficult for clinicians. Presently, the communication strategies used by pediatric oncologists to approach goals of care conversations are not well understood. We recorded disease re-evaluation conversations between pediatric oncologists, patients, and parents, capturing 141 conversations (∼2400 minutes) for 17 patients with advancing illness across the study period. We conducted content analysis to identify strategies for broaching goals-of-care conversations and found five distinct communication approaches, which were not mutually exclusive. Further research is needed to explore patient and family views on best practices for broaching discussions about goals of care.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  cancer; communication; goals of care; oncologist; pediatric

Mesh:

Year:  2021        PMID: 34357679      PMCID: PMC8422283          DOI: 10.1002/pbc.29270

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.838


  11 in total

1.  Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer.

Authors:  P S Hinds; L Oakes; W Furman; P Foppiano; M S Olson; A Quargnenti; J Gattuso; B Powell; D K Srivastava; D Jayawardene; J T Sandlund; C Strong
Journal:  Oncol Nurs Forum       Date:  1997-10       Impact factor: 2.172

2.  REMAP: A Framework for Goals of Care Conversations.

Authors:  Julie W Childers; Anthony L Back; James A Tulsky; Robert M Arnold
Journal:  J Oncol Pract       Date:  2017-04-26       Impact factor: 3.840

3.  Communication Challenges of Oncologists and Intensivists Caring for Pediatric Oncology Patients: A Qualitative Study.

Authors:  Folasade Odeniyi; Pamela G Nathanson; Theodore E Schall; Jennifer K Walter
Journal:  J Pain Symptom Manage       Date:  2017-08-12       Impact factor: 3.612

4.  Opening the black box: how do physicians communicate about advance directives?

Authors:  J A Tulsky; G S Fischer; M R Rose; R M Arnold
Journal:  Ann Intern Med       Date:  1998-09-15       Impact factor: 25.391

5.  Helping parents make and survive end of life decisions for their seriously ill child.

Authors:  Pamela S Hinds; Katherine Patterson Kelly
Journal:  Nurs Clin North Am       Date:  2010-09       Impact factor: 1.208

6.  "Trying to be a good parent" as defined by interviews with parents who made phase I, terminal care, and resuscitation decisions for their children.

Authors:  Pamela S Hinds; Linda L Oakes; Judy Hicks; Brent Powell; Deo Kumar Srivastava; Sheri L Spunt; Joann Harper; Justin N Baker; Nancy K West; Wayne L Furman
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

7.  Conflicting goals and obligations: Tensions affecting communication in pediatric oncology.

Authors:  Bryan A Sisk; Ginny Schulz; Erica C Kaye; Justin N Baker; Jennifer W Mack; James M DuBois
Journal:  Patient Educ Couns       Date:  2021-05-07

8.  Prognostic Communication Between Oncologists and Parents of Children With Advanced Cancer.

Authors:  Erica C Kaye; Melanie Stall; Cameka Woods; Srilakshmi Velrajan; Melanie Gattas; Monica Lemmon; Justin N Baker; Jennifer W Mack
Journal:  Pediatrics       Date:  2021-05-05       Impact factor: 9.703

Review 9.  Communicating Effectively in Pediatric Cancer Care: Translating Evidence into Practice.

Authors:  Lindsay J Blazin; Cherilyn Cecchini; Catherine Habashy; Erica C Kaye; Justin N Baker
Journal:  Children (Basel)       Date:  2018-03-11

10.  Longitudinal investigation of prognostic communication: Feasibility and acceptability of studying serial disease reevaluation conversations in children with high-risk cancer.

Authors:  Erica C Kaye; Melanie Gattas; Myra Bluebond-Langner; Justin N Baker
Journal:  Cancer       Date:  2019-09-18       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.